JOURNAL OF SHANDONG UNIVERSITY(NATURAL SCIENCE) ›› 2016, Vol. 51 ›› Issue (7): 121-125.doi: 10.6040/j.issn.1671-9352.0.2016.119
Previous Articles Next Articles
ZHANG Yan1,2, WEI Yu-ping1, ZHANG Liang1,2, FU Yan-kai1,2, XU Jian-dong1, XU Xia1*
CLC Number:
[1] Alzheimers Association. 2015 Alzheimers disease facts and figures[J]. Alzheimers & Dementia, 2015, 11(3):332-384. [2] SORENSEN A A. Alzheimers disease research: scientific productivity and impact of the top 100 investigators in the field[J]. Journal of Alzheimers Disease, 2009, 16(3):451-465. [3] LUKENS J N, VAN DEERLIN V, CLARK C M, et al. Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimers disease[J]. Alzheimers & Dementia, 2009, 5(6):463-469. [4] MONTE S M, WANDS J R. The AD7c-NTP neuronal thread protein biomarker for detecting Alzheimers disease[J]. Journal of Alzheimers Disease, 2001, 3(3):345-353. [5] WANG C, CUI Y, YANG J, et al. Combining serum and urine biomarkers in the early diagnosis of mild cognitive impairment that evolves into Alzheimers disease in patients with the apolipoprotein E ε4 genotype[J]. Biomarkers, 2015, 20(1):84-88. [6] GOODMAN I, GOLDEN G, FLITMAN S, et al. A multi-center blinded prospective study of urine neural thread protein measurements in patients with suspected Alzheimers disease[J]. Journal of the American Medical Directors Association, 2007, 8(1):21-30. [7] YOUN Y C, PARK K W, HAN S H, et al. Urine neural thread protein measurements in Alzheimer disease[J]. Journal of the American Medical Directors Association, 2011, 12(5):372-376. [8] LEVY S, MCCONVILLE M, LAZARO G A, et al. Competitive ELISA studies of neural thread protein in urine in Alzheimers disease[J]. Journal of Clinical Laboratory Analysis, 2007, 21(1):24-33. [9] LIPMAN N S, JACKSON L R, TRUDEL L J, et al. Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources[J]. ILAR Journal, 2005, 46(3):258-268. [10] YANG J, YAN R, ROY A, et al. The I-TASSER Suite: protein structure and function prediction[J]. Nature Methods, 2015, 12(1):7-8. [11] ROY A, KUCUKURAL A, ZHANG Y. I-TASSER: a unified platform for automated protein structure and function prediction[J]. Nature Protocols, 2010, 5(4):725-738. [12] ZHANG Y. I-TASSER server for protein 3D structure prediction[J]. BMC bioinformatics, 2008, 9(1):40-47. [13] MONTE S M, GHANBARI K, FREY W H, et al. Characterization of the AD7C-NTP cDNA expression in Alzheimers disease and measurement of a 41-kD protein in cerebrospinal fluid[J]. Journal of Clinical Investigation, 1997, 100(12):3093-3104. [14] WEI Y P, XU J D, ZHANG L, et al. Development of novel small peptide ligands for antibody purification[J]. RSC Advances, 2015, 5(82):67093-67096. [15] ZHANG J, SHI S L. A literature review of AD7c-ntp as a biomarker for Alzheimers disease[J]. Annals of Indian Academy Neurology, 2013, 16(3):307-319. [16] MA L, CHEN J, WANG R, et al. The level of Alzheimer-associated neuronal thread protein in urine may be an important biomarker of mild cognitive impairment[J]. Journal of Clinical Neuroscience, 2015, 22(4):649-652. |
No related articles found! |
|